Patents
Patents for C07J 19 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 by a lactone ring (362)
03/2015
03/05/2015WO2015029035A1 SELECTIVE INHIBITORS OF α2 ISOFORM OF Na,K-ATPase AND USE FOR REDUCTION OF INTRA-OCULAR PRESSURE
02/2015
02/24/2015US8962602 Anticancer steroidal lactones unsaturated in position 7 (8)
01/2015
01/20/2015US8937058 17-hydroxy-19-nor-21-carboxylic acid-steroid γ-lactone derivative, use thereof, and medicament containing the derivative
12/2014
12/23/2014US8916346 Reagents and methods for direct labeling of nucleotides
09/2014
09/25/2014WO2014150127A1 Redistribution of mogrol glycoside content
06/2014
06/04/2014CN102532235B Bufogenin derivative and preparation method thereof, composition containing bufogenin derivative and applications thereof
05/2014
05/07/2014CN102203112B 某些化合物、组合物及方法 Some of the compounds, compositions and methods
04/2014
04/02/2014CN102492011B Method for preparing antibacterial compound from scorpion
03/2014
03/05/2014CN103619865A Certain chemical entities, compositions, and methods
01/2014
01/02/2014US20140005132 Contraceptive agents
12/2013
12/26/2013US20130345186 Certain chemical entities, compositions, and methods
11/2013
11/27/2013CN103408627A Method for extracting and purifying euonymin A
10/2013
10/30/2013EP2655390A2 Purified cardiogenin isomer and related methods
09/2013
09/04/2013CN103282371A Purified cardiogenin isomer and related methods
08/2013
08/21/2013CN103254263A Cardiac glycoside compound and preparation method as well as application thereof
06/2013
06/13/2013US20130150254 Reagents and methods for direct labeling of nucleotides
05/2013
05/14/2013CA2641303C Na/k-atpase ligand
05/09/2013US20130115316 Indolealkylamino-withasteroid conjugates and method of use
04/2013
04/24/2013CN103059088A Dammarane saponin derivatives with novel structure as well as preparation method and anti-microbial application thereof
04/03/2013CN103006670A Total unsaturated toad lactone, and preparation method and use thereof
03/2013
03/06/2013EP2563803A1 Anticancer steroidal lactones unsaturated in position 7 (8)
02/2013
02/27/2013CN102947322A Anticancer steroidal lactones unsaturated in position 7 (8)
02/27/2013CN102101878B Hellebore petunidin space isomer compound and preparation and application thereof
01/2013
01/30/2013CN102898494A Method for preparing periplocin
01/17/2013WO2012088264A3 Purified cardiogenin isomer and related methods
01/09/2013CN102101879B Arenobufagin space isomer compound and preparation and application thereof
01/03/2013WO2013000286A1 Bufogenin derivatives, preparation methods, compositions containing such derivatives and uses thereof
11/2012
11/21/2012EP2523966A1 Certain chemical entities, compositions, and methods
11/08/2012WO2012149667A1 Cardenolide compounds and antitumor use thereof
09/2012
09/05/2012CN102656179A Bufalin derivatives, pharmaceutical compositions and use thereof
08/2012
08/22/2012CN102643321A Separation and preparation method of acnistin B and E
08/09/2012WO2012103810A1 Certain chemical entities, compositions, and methods
07/2012
07/17/2012US8222237 Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones
07/04/2012CN102532235A Bufogenin derivative and preparation method thereof, composition containing bufogenin derivative and applications thereof
06/2012
06/28/2012WO2012088264A2 Purified cardiogenin isomer and related methods
06/28/2012CA2822694A1 Purified cardiogenin isomer and related methods
06/13/2012CN102492011A Method for preparing antibacterial compound from scorpion
03/2012
03/08/2012WO2012027957A1 Bufalin derivatives, pharmaceutical compositions and use thereof
01/2012
01/25/2012EP1993672B1 Use of cardiotonic steroids as Na/K-ATPase ligands for the treatment of the skin
11/2011
11/03/2011WO2011134954A1 Anticancer steroidal lactones unsaturated in position 7 (8)
10/2011
10/19/2011CN102219821A Cardiac glycoside compounds and antitumor application thereof
09/2011
09/28/2011CN102203112A Certain chemical entities, compositions, and methods
08/2011
08/25/2011US20110207154 Method for determination of marinobufagenin levels and compounds employable in such method
08/17/2011CN101463062B Compound separated from Gynostemma pentaphylla total saponin acid hydrolysis products
07/2011
07/21/2011WO2011085641A1 Certain chemical entities, compositions, and methods
07/21/2011CA2786465A1 Certain chemical entities, compositions, and methods
06/2011
06/22/2011CN102101879A Arenobufagin space isomer compound and preparation and application thereof
06/22/2011CN102101878A Hellebore petunidin space isomer compound and preparation and application thereof
05/2011
05/18/2011EP2320729A1 Glycoside compounds and pharmaceutical compositions thereof
05/04/2011CN101491531B Use of bufadienolides compound and bufadienolides salinization compound in preparing medicine for treating gynecological tumor
04/2011
04/27/2011CN102030796A Several cardiac glycoside compounds separated from rosebay and applications thereof
12/2010
12/29/2010CN101485666B Application of Gamabufotalin and salt thereof in preparing medicament for treating gynaecologic tumor
09/2010
09/16/2010WO2010102673A1 Hellebrin and hellebrigenin derivatives
06/2010
06/30/2010CN101759753A Rhodexin A preparation method
01/2010
01/20/2010CN100582120C 21-subunit digoxin derivative and preparation method thereof
12/2009
12/16/2009CN100569793C Toad sterene compounds and application thereof in pharmaceutical preparation
12/03/2009DE102008026793A1 C-Ring-substituierte Pregn-4-en-21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate C-ring-substituted pregn-4-ene-21,17-carbolactones, and pharmaceutical compositions containing them
09/2009
09/23/2009CN101537027A Extract with anti-lung cancer activity of streptocaulon juventas (Loureiro) Merrill and preparation process of compounds thereof
09/17/2009DE102007063495A1 19-Nor-Steroidderivate mit einer 15α,16α-Methylengruppe und einem gesättigten 17,17-Spirolactonring, deren Verwendung sowie diese Derivate enthaltende Arzneimittel 19-nor-steroid derivatives with a 15α, 16α-methyl group and a saturated 17,17-spirolactone, the use of these derivatives and pharmaceutical compositions containing them
08/2009
08/25/2009CA2455097C Enzyme inhibition immunoassay based on impdh inhibition by mpa
07/2009
07/02/2009DE102007063503A1 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel 17-hydroxy-19-nor-21-carboxylic acid y-lactone steroid derivative, its use and pharmaceutical compositions containing the derivative
07/02/2009DE102007063501A1 15, 16-Methylen-17-hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel 15, 16-methylene-17-hydroxy-19-nor-21-carboxylic acid y-lactone steroid derivative, its use and pharmaceutical compositions containing the derivative
07/02/2009DE102007063500A1 17-(1'-Propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel 17- (1'-propenyl) -17-3'-oxidoestra-4-en-3-one derivative, its use and pharmaceutical compositions containing the derivative
07/02/2009DE102007063499A1 Steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel Steroid-17,17-lactol derivative, the use of the derivative and pharmaceutical compositions containing them
07/02/2009DE102007063498A1 15,16-Methylen-steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel 15,16-methylene steroid-17,17-lactol derivative, the use of the derivative and pharmaceutical compositions containing them
07/02/2009DE102007063496A1 15,16-Methylen-17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel 15,16-methylene-17- (1'-propenyl) -17-3'-oxidoestra-4-en-3-one derivative, its use and pharmaceutical compositions containing the derivative
06/2009
06/24/2009CN101463062A Compound separated from Gynostemma pentaphylla total saponin acid hydrolysis products
04/2009
04/01/2009CN101400690A Modulators of hypoxia inducible factor-1 and related uses
03/2009
03/19/2009WO2009033505A1 Hellebrin derivatives
01/2009
01/13/2009US7476727 Conjugates of mycophenolic acid
11/2008
11/26/2008EP1993672A2 Na/k-atpase ligand
10/2008
10/16/2008US20080255059 Regulators of the hedgehog pathway, compositions and uses related thereto
10/15/2008CN101284859A Panaxadiol saponin microbial conversion hydrolysate and method for preparing same
09/2008
09/24/2008EP1971618A2 Modulators of hypoxia inducible factor-1 and related uses
08/2008
08/14/2008WO2007081835A3 Modulators of hypoxia inducible factor-1 and related uses
08/07/2008US20080188425 Dihydroouabain-like factor and diagnostic & therapeutic compositions and methods
04/2008
04/30/2008CN100384866C Process for prepn. of 7 alpha-carboxyl 9,11-epoxy steroids and intermediates useful therein and a general process for epoxidation of olifinic double bonds
03/2008
03/06/2008WO2007089688A3 Na/k-atpase ligand
01/2008
01/23/2008EP1105730B1 Enzyme inhibition immunoassay
01/08/2008CA2503006C Cyclooxygenase-2 inhibitory withanolide compositions and method
10/2007
10/17/2007CN100343271C C27-steroid antitumour medicine
09/2007
09/26/2007CN101041683A 21-subunit digoxin derivative and preparation method thereof
08/2007
08/15/2007CN101016327A Toad sterene compounds, preparing method and application thereof
08/15/2007CN101016326A Toad sterene compounds and application thereof in pharmaceutical preparation
08/09/2007CA2641303A1 Na/k-atpase ligand
07/2007
07/09/2007CA2635370A1 Modulators of hypoxia inducible factor-1 and related uses
06/2007
06/26/2007US7235675 Conjugates of mycophenolic acid
06/21/2007US20070142631 Enzyme inhibiton immunoassay
06/20/2007EP0973791B1 Process for the preparation of an epoxy compound
05/2007
05/10/2007WO2006120472A3 Novel beta-steroid compounds
03/2007
03/15/2007US20070060746 Processes for preparation of 9,11 epoxy steroids and intermediates useful therein
11/2006
11/23/2006US20060264412 Carbonylation; hydrogenation; for preparation of eplerenone
11/16/2006WO2006120472A2 Novel beta-steroid compounds
11/09/2006US20060252737 18-Methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter
10/2006
10/31/2006US7129345 Keto-substituted steroid compounds
10/25/2006CN1850847A Method for preparing periplogenin
09/2006
09/27/2006CN1839145A Steroid spirolactonization
08/2006
08/08/2006US7087590 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them
08/02/2006CN1810827A Anticancer prepn containing three anticancer compounds of toad or toad cake and its prepn process
08/01/2006CA2341263C Enzyme inhibition immunoassay
1 2 3 4